Barrett McGrath is an executive with more than 24 years of commercial and business development experience in the biopharmaceutical industry. He has worked with mid-size companies as well start-up and emerging Life Sciences concerns. Most recently, Barrett served as Executive Director, Alliance and Portfolio Management with Novaquest (formerly PharmaBio Development), the strategic investment unit of Quintiles Transnational. In this capacity, he was responsible for oversight of new and established product development and commercialization partnerships with early stage and emerging biotechnology companies.

Barrett has also served as a consultant to the Life Sciences industry, providing both commercial and business development services to privately held companies, and helping guide them through several levels of financing, including IPOs. Notable among these is Tercica Inc., founded in 2001 and having an IPO in 2003. During this engagement, Barrett had an instrumental role in Tercica’s successful migration from New Zealand to the United States, the raising of a Series A financing, and closing the in-licensing of their lead compound, IGF-I, from Genentech.

Barrett’s career began in 1982 with American Critical Care, a pharmaceutical division of American Hospital Supply Corporation (ACC was subsequently acquired by Du Pont Pharmaceuticals). During his tenure at ACC/Du Pont, he held positions of increasing responsibility in sales and marketing/brand management. Barrett then joined Genentech in 1989, where he remained for 11 years, and again held positions of increasing responsibility in sales management and marketing management.

Barrett received his Bachelor of Science Degree in Business Administration/Marketing from the University of Tennessee in 1982. He is married, with three children, and resides in Los Altos, California.